DBV Technologies (DBVT) Leases (2019 - 2026)
DBV Technologies (DBVT) reported Leases of $4.2 million for Q1 2026, down 25.17% year-over-year from $5.6 million in Q1 2025, and down 8.7% on a QoQ basis from $4.6 million in Q4 2025.
DBV Technologies (DBVT) has 8 years of Leases data on file, last reported at $4.2 million in Q1 2026.
- Quarterly Leases fell 25.17% year-over-year to $4.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.2 million (down 25.17% YoY) and the FY2025 annual result came in at $4.6 million, down 16.39% from the prior year.
- Leases fell to $4.2 million in Q1 2026 per DBVT's latest filing, from $4.6 million in the prior quarter.
- Across five years, Leases topped out at $6.6 million in Q1 2024 and bottomed at $1.4 million in Q3 2023.
- The 5-year median for Leases is $4.6 million (2025), against an average of $4.2 million.
- The widest annual swing landed in 2022, when Leases tumbled 66.81%; it then surged 331.1% in 2024.
- Tracing DBVT's Leases over 5 years: stood at $2.5 million in 2022, then soared by 108.79% to $5.2 million in 2023, then climbed by 4.86% to $5.5 million in 2024, then decreased by 16.39% to $4.6 million in 2025, then slipped by 8.7% to $4.2 million in 2026.
- Per Business Quant, the three latest DBVT Leases figures stand at $4.2 million (Q1 2026), $4.6 million (Q4 2025), and $5.6 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 83,048.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 61,822.50 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 285.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.69 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 189.30 Mn |
| 10 | DBV Technologies | 8.00 Bn | 7.77 Bn | -3.90 Mn | 4.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.20 Mn |
| Dec 31, 2025 | 4.60 Mn |
| Sep 30, 2025 | 5.59 Mn |
| Jun 30, 2025 | 5.78 Mn |
| Mar 31, 2025 | 5.61 Mn |
| Dec 31, 2024 | 5.50 Mn |
| Sep 30, 2024 | 5.99 Mn |
| Jun 30, 2024 | 5.96 Mn |
| Mar 31, 2024 | 6.55 Mn |
| Dec 31, 2023 | 5.25 Mn |
| Sep 30, 2023 | 1.39 Mn |
| Jun 30, 2023 | 1.83 Mn |
| Mar 31, 2023 | 2.13 Mn |
| Dec 31, 2022 | 2.51 Mn |
| Sep 30, 2022 | 2.61 Mn |
| Jun 30, 2022 | 3.15 Mn |
| Mar 31, 2022 | 3.36 Mn |
| Dec 31, 2021 | 7.34 Mn |
| Sep 30, 2021 | 7.88 Mn |
| Jun 30, 2021 | 8.63 Mn |
| Mar 31, 2021 | 9.17 Mn |
| Dec 31, 2020 | 10.10 Mn |
| Dec 31, 2019 | 23.59 Mn |